Print Page  Close Window

SEC Filings

OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
Table of Contents

The following table sets forth information about the beneficial ownership of our common stock at March 31, 2007, and as adjusted to reflect the sale of the shares of common stock in this offering, for:
  •      each person known to us to be the beneficial owner of more than 5% of our common stock;
  •      each named executive officer;
  •      each of our directors; and
  •      all of our executive officers and directors as a group.
Unless otherwise noted below, the address of each beneficial owner listed on the table is c/o Orexigen Therapeutics, Inc., 12481 High Bluff Drive, Suite 160, San Diego, CA 92130. We have determined beneficial ownership in accordance with the rules of the Securities and Exchange Commission. Except as indicated by the footnotes below, we believe, based on the information furnished to us by the stockholders, that the persons and entities named in the tables below have sole voting and investment power with respect to all shares of common stock that they beneficially own, subject to applicable community property laws. We have based our calculation of the percentage of beneficial ownership “prior to offering” on 18,860,270 shares of common stock outstanding on March 31, 2007, which assumes the conversion of all outstanding shares of preferred stock into common stock, and our calculation of the percentage of beneficial ownership “after offering” on 24,860,270 shares of common stock outstanding upon completion of this offering.
In computing the number of shares of common stock beneficially owned by a person and the percentage ownership of that person, we deemed outstanding shares of common stock subject to options held by that person that are currently exercisable or exercisable within 60 days of March 31, 2007. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other person. Beneficial ownership representing less than 1% is denoted with an asterisk (*).
        Percentage of
    Number of
  Common Stock
  Beneficially Owned
  Prior to
Beneficial Owner
  Owned   Offering   Offering
5% or Greater Stockholders:
Funds affiliated with Domain Associates, L.L.C.(1)
    4,023,807       21.3 %     16.2 %
One Palmer Square, Suite 515
Princeton, NJ 08542
KPCB Holdings, Inc.(2)
    3,763,807       20.0       15.1  
2750 Sand Hill Road
Menlo Park, CA 94025
Funds affiliated with Sofinnova Venture Partners VI, L.P.(3)
    2,822,854       15.0       11.4  
140 Geary Street, Tenth Floor
San Francisco, CA 94108
Scale Venture Partners II, LP(4)
    2,797,424       14.8       11.3  
950 Tower Lane, Suite 700
Foster City, CA 94404
Funds affiliated with Montreux Equity Partners(5)
    1,398,712       7.4       5.6  
3000 Sand Hill Road
Bldg #1, Suite 260
Menlo Park, CA 94025
Morgenthaler Partners VII, L.P.(6)
    1,118,969       5.9       4.5  
2710 Sand Hill Road, Suite 100
Menlo Park, CA 94025